Recent progress in the immunohistochemistry of solid tumors

H Battifora1

  • 1Division of Anatomic Pathology, City of Hope National Medical Center, Duarte, CA 91010.

Improved, more sensitive, immunohistochemical methods and the development of monoclonal antibodies are simplifying the task of solving problems in the diagnosis of tumors in surgical pathology. Presented in this paper is our experience with the antibodies most frequently used in our laboratory to solve common problems in the surgical pathology of solid neoplasms. These are antibodies to keratins, leukocyte common antigen, protein S100, milk fat globule-derived antigen, and antibodies to basal lamina antigens.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...